Lee W Jones Selected Research

Exercise Therapy (Therapy, Exercise)

12/2021	Effects and tolerability of exercise therapy modality on cardiorespiratory fitness in lung cancer: a randomized controlled trial.
1/2020	Effects of Exercise Therapy Dosing Schedule on Impaired Cardiorespiratory Fitness in Patients With Primary Breast Cancer: A Randomized Controlled Trial.
11/2019	Development of Exercise as Interception Therapy for Cancer: A Review.
1/2018	Exercise Therapy and Cardiovascular Toxicity in Cancer.
1/2018	Efficacy of Exercise Therapy on Cardiorespiratory Fitness in Patients With Cancer: A Systematic Review and Meta-Analysis.
1/2017	Bench-to-Bedside Approaches for Personalized Exercise Therapy in Cancer.
5/2013	The effects of inpatient exercise therapy on the length of hospital stay in stages I-III colon cancer patients: randomized controlled trial.
4/2013	Exercise therapy as treatment for cardiovascular and oncologic disease after a diagnosis of early-stage cancer.
3/2013	Effects and potential mechanisms of exercise training on cancer progression: a translational perspective.
2/2013	Exercise-oncology research: past, present, and future.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lee W Jones Research Topics

Disease

67	Neoplasms (Cancer) 04/2022 - 05/2003
45	Breast Neoplasms (Breast Cancer) 06/2022 - 05/2003
11	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 05/2003
10	Cardiotoxicity 01/2020 - 01/2011
9	Fatigue 12/2014 - 05/2003
8	Lung Neoplasms (Lung Cancer) 12/2021 - 03/2009
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 08/2012
6	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 05/2013
5	Obesity 01/2022 - 12/2013
5	Neoplasm Metastasis (Metastasis) 01/2017 - 02/2010
4	Inflammation (Inflammations) 12/2020 - 04/2009
4	Weight Loss (Weight Reduction) 02/2020 - 08/2014
4	Insulin Resistance 02/2020 - 08/2003
3	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 11/2015
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2014 - 02/2007
3	Hypoxia (Hypoxemia) 09/2013 - 02/2010
3	Brain Neoplasms (Brain Tumor) 11/2010 - 05/2006
2	Body Weight (Weight, Body) 01/2022 - 03/2007
2	Pathologic Complete Response 01/2022 - 01/2017
2	Hypertension (High Blood Pressure) 01/2019 - 01/2016
2	Sarcopenia 01/2019 - 01/2016
2	Weight Gain 01/2019 - 08/2015
2	Chronic Disease (Chronic Diseases) 01/2017 - 12/2014
2	Lymphoma (Lymphomas) 12/2016 - 05/2005
2	Left Ventricular Dysfunction 07/2013 - 08/2009
2	Dyspnea (Shortness of Breath) 06/2012 - 03/2009
2	Chronic Obstructive Pulmonary Disease (COPD) 06/2012 - 03/2009
2	Glioblastoma (Glioblastoma Multiforme) 04/2011 - 08/2009
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 12/2020
1	Thoracic Aortic Aneurysm 01/2020
1	Aortic Dissection 01/2020
1	Bicuspid Aortic Valve Disease 01/2020
1	Heart Diseases (Heart Disease) 03/2017
1	Hyperlipidemias (Hyperlipidemia) 01/2016
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2016

Drug/Important Bio-Agent (IBA)

14	Biomarkers (Surrogate Marker)IBA 12/2020 - 08/2003
7	Biological ProductsIBA 12/2020 - 12/2013
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 09/2005
6	AnthracyclinesIBA 01/2020 - 05/2007
6	Trastuzumab (Herceptin)FDA Link 01/2020 - 05/2007
5	Insulin (Novolin)FDA Link 11/2017 - 08/2003
5	Clostridium perfringens epsilon-toxinIBA 04/2017 - 02/2007
4	AndrogensIBA 01/2022 - 05/2003
4	C-Reactive ProteinIBA 12/2020 - 09/2005
4	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 08/2003
3	LeptinIBA 02/2020 - 01/2016
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 09/2013
2	Metformin (Glucophage)FDA LinkGeneric 12/2020 - 02/2020
2	Interleukin-6 (Interleukin 6)IBA 12/2020 - 01/2016
2	Cytotoxins (Cytolysins)IBA 01/2020 - 04/2011
2	AdipokinesIBA 11/2017 - 09/2013
2	pertuzumabIBA 01/2017 - 04/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 04/2016
2	taxaneIBA 04/2016 - 05/2007
2	AdiponectinIBA 01/2016 - 09/2013
2	CholesterolIBA 05/2015 - 08/2012
2	beta-Aminoethyl Isothiourea (AET)IBA 01/2014 - 09/2013
2	Insulin-Like PeptidesIBA 09/2013 - 08/2003
2	Insulin-Like Growth Factor I (IGF-1)IBA 09/2013 - 08/2003
2	Insulin-Like Growth Factor Binding ProteinsIBA 09/2013 - 08/2003
2	CytokinesIBA 09/2013 - 09/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2012 - 04/2011
2	Complement System Proteins (Complement)IBA 06/2012 - 05/2006
2	Oxygen (Dioxygen)IBA 04/2010 - 06/2009
2	Hormones (Hormone)IBA 10/2007 - 05/2003
1	enzalutamideIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2020
1	Cytidine Monophosphate (CMP)IBA 11/2019
1	SolutionsIBA 01/2019
1	Phosphocreatine (Neoton)IBA 01/2018
1	CarbonIBA 01/2018
1	Cardiac GlycosidesIBA 11/2017
1	ClaudinsIBA 11/2017
1	salicylhydroxamic acid (SHAM)IBA 11/2017
1	Digoxin (Digitek)FDA LinkGeneric 11/2017
1	CarcinogensIBA 01/2017
1	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2016
1	Troponin IIBA 04/2016
1	HDL CholesterolIBA 01/2016

Therapy/Procedure

64	Therapeutics 06/2022 - 05/2003
20	Drug Therapy (Chemotherapy) 01/2022 - 05/2003
17	Exercise Therapy (Therapy, Exercise) 12/2021 - 06/2009
7	Adjuvant Chemotherapy 01/2022 - 09/2005
4	Neoadjuvant Therapy 01/2022 - 09/2013
4	Resistance Training 12/2021 - 04/2010
4	Cell Transplantation 01/2019 - 11/2015
4	Radiotherapy 07/2015 - 05/2003
3	Aftercare (After-Treatment) 11/2020 - 01/2016
3	Thoracotomy 06/2014 - 05/2013
2	Immunotherapy 01/2020 - 01/2019
2	Caloric Restriction 01/2020 - 01/2016
2	Cardiac Rehabilitation 01/2020 - 01/2019
2	Stem Cell Transplantation 12/2016 - 02/2015
2	Hematopoietic Stem Cell Transplantation 02/2016 - 02/2015
2	Prostatectomy (Retropubic Prostatectomy) 01/2015 - 05/2014
2	Complementary Therapies (Alternative Medicine) 05/2013 - 12/2006
1	Wearable Electronic Devices 04/2022
1	Castration 01/2022
1	Patient Readmission 01/2020